Janus Henderson Group PLC Raises Stake in Inspire Medical Systems, Inc. (NYSE:INSP)

Janus Henderson Group PLC increased its stake in Inspire Medical Systems, Inc. (NYSE: INSP – Open if you don’t have a Pro membership) by 5.8% during the third quarter, the company disclosed in its filing with the Securities & Exchange Commission. The company thus owned 502,609 shares of the company’s stock after buying 27,374 shares in the said period. Janus Henderson Group PLC owned approximately 1.68% of Inspire Medical Systems, which was worth $106,075,000 as of its most recent filing with the Securities and Exchange Commission.

Thus, a number of other large investors have also recently bought and sold shares of INSP. As a result of the acquisitions made during the third quarter, Allspring Global Investments Holdings LLC increased its holdings of Inspire Medical Systems by 798. 3% or 238034 shares. Allspring Global Investments Holdings LLC thus purchased additional shares of the company’s stock to bring its ownership to 267852 shares of the company’s stock which is now valued at $56. 5 million in the course of the last quarter. BNY Mellon boosted their holdings in Inspire Medical Systems by 32. 3% over the second quarter when it bought 192238 more shares. BNY Mellon Corp now owns 787815 shares of the company’s stock an increase of 192238 shares from the previous quarter’s total.

AQR Capital Management LLC boosted the portfolio’s holdings in Inspire Medical Systems by 152. 7% in the 2nd quarter. AQR Capital Management LLC acquired a total of 140,090 shares of the company’s stock through purchases made in the last quarter bringing the company’s ownership to 231845 shares of the company’s stock which is now worth $31,028,000.

Learn Market Beasts Latest Stock Analysis on Inspire Medical Systems

Inspire Medical Systems Systems (NYSE:INSP) shares was opened at $196. 92 on Thursday. Inspire Medical Systems has a one year low of $123 and a one year high of $257. 40. The company has a market cap of $5. 90B, the P/E ratio is 184. 04 and the beta is 1. 31.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings results on Monday, Nov 4. The company delivered a per share earnings of $0. 60 for the quarter, which best the consensus estimate of $0. 06. Inspire Medical Systems had a net profit margin of 4. 37% and the return on total assets was 5. 30%. The revenue of the company for the quarter was $203. 20m which was up by 32. 6% from the same quarter last year. This trade represented a 3. 34 % decrease in their position. The sale was made and thus recorded in a legal filing with the Securities & Exchange Commission which can be viewed through this link. 4. 10% of the stock is owned by the company’s corporate insiders.

Several equities research analysts have commented on the company. Bank of America upgraded the stock and the price target to buy from neutral and to $255 from $220 per share on the stock of Inspire Medical Systems in a research report published on Wednesday, November 20. Royal Bank of Canada restated an “outperform” rating for the stock and gave it a “buy” rating with a price target of $260 for the company’s stock in a research report released on Tuesday, November 5. Leerink Partners increased the price objective of Inspire Medical Systems to $197 from a previous price target of $167 and gave the stock a “market perform” rating in a research note issued on Tuesday, September 10. KeyCorp lowered the price target of their analysis on Inspire Medical Systems to $278. 0 from $318. 0 and upgraded the stock to an “overweight” rating in a research note issued on Wednesday, August 7.

Before you consider Inspire Medical Systems, you'll want to hear this.

MarketBeat tracks the ratings and recommendations of Wall Street analysts and the information they provide to their clients. MarketBeat has identified the five stocks that analysts are suggesting to their clients to buy now before the broader market catches on... and Inspire Medical Systems wasn’t one of them.

While the above mentioned analysts have given a “Moderate Buy” rating to Inspire Medical Systems, top-rated analysts believe these five stocks are better buys.